Diabetic Neuropathy Treatment in Ayurveda
Diabetic Neuropathy: An Ayurvedic Perspective
Table of Contents
Introduction
Diabetic neuropathy, a common complication of long-term diabetes, affects the nerves due to persistent high blood sugar levels and oxidative stress (American Diabetes Association, 2022). It manifests in various forms, including peripheral, autonomic, proximal, and focal neuropathy, impacting a patient’s quality of life. Symptoms range from pain, tingling, and numbness in the extremities to digestive and cardiovascular dysfunctions (Jones & Smith, 2020).
While modern medicine focuses on managing symptoms through medications, Ayurveda offers a holistic approach by addressing the root cause of the condition, balancing the doshas, and enhancing nerve health (Gupta & Singh, 2017). At the Diabetes Reversal Clinic, under the guidance of Dr. Soumya Hullanavar, we specialize in personalized Ayurvedic care to manage and reverse diabetic neuropathy effectively (EliteAyurveda, 2023).
Types of Diabetic Neuropathy
| Type | Affected Area | Symptoms |
|---|---|---|
| Peripheral Neuropathy | Hands and feet | Tingling, numbness, burning pain, sensitivity to touch (American Diabetes Association, 2022). |
| Autonomic Neuropathy | Internal organs | Digestive issues, bladder dysfunction, sexual problems, abnormal heart rate (Brown & White, 2018). |
| Proximal Neuropathy | Thighs, hips, buttocks | Severe pain, weakness in legs, difficulty rising from a seated position (Jones & Smith, 2020). |
| Focal Neuropathy | Specific nerves in the head, torso, or legs | Sudden pain or weakness, vision changes, Bell’s palsy-like symptoms (American Academy of Neurology, 2021). |
Ayurvedic Insights on Diabetic Neuropathy
In Ayurveda, diabetic neuropathy is viewed as a condition caused by aggravated Vata dosha and toxin (Ama) accumulation, which obstruct the flow of nutrients and energy in the Prana Vaha Srotas (nerve channels) (Chauhan, 2021). This results in nerve damage, pain, and dysfunction.
Key Ayurvedic Concepts
- Vata Imbalance: Leads to dryness, degeneration, and impaired nerve function (Gupta & Singh, 2017).
- Ama Accumulation: Blocks energy flow and worsens inflammation (Sharma, 2018).
- Weakened Agni (Digestive Fire): Impairs metabolism and nerve nourishment (Chauhan, 2021).
Symptoms of Diabetic Neuropathy
- Tingling, burning, or shooting pain in extremities (American Diabetes Association, 2022).
- Muscle weakness or cramping (Jones & Smith, 2020).
- Digestive irregularities, including constipation or diarrhea (Brown & White, 2018).
- Dizziness or fainting due to blood pressure fluctuations (Gupta & Singh, 2017).
- Sexual dysfunction and bladder problems (Sharma, 2018).
Ayurvedic Management of Diabetic Neuropathy
1. Balancing Vata Dosha
- Therapies: Abhyanga (oil massage) with medicated oils like Mahanarayana or Bala Taila to calm Vata and improve nerve conductivity (Chauhan, 2021).
- Lifestyle Changes: Warm oil applications and maintaining a warm, stress-free environment to balance Vata (Gupta & Singh, 2017).
2. Detoxification (Ama Removal)
- Dietary Practices: Including light, easily digestible foods to clear Ama and improve digestion (Sharma, 2018).
- Panchakarma Alternatives: Gentle detox therapies to cleanse the body and restore channel function (Chauhan, 2021).
3. Nerve Nourishment
- Herbal Formulations: Ashwagandha and Shatavari to rejuvenate and strengthen nerve tissues (Gupta & Singh, 2017).
- Triphala and Brahmi: Support detoxification and nerve repair (Chauhan, 2021).
4. Pain Management
- External Applications: Herbal poultices (Lepa) and warm compresses to relieve pain and inflammation (Sharma, 2018).
- Oral Medications: Formulations with turmeric and fenugreek to reduce oxidative stress and inflammation (Gupta & Singh, 2017).
5. Lifestyle and Stress Management
- Yoga and Pranayama: Asanas like Vajrasana and breathing techniques like Nadi Shodhana to improve nerve function and circulation (Sharma, 2018).
- Mindfulness Practices: Meditation to reduce stress, a key trigger for Vata aggravation (Chauhan, 2021).
Comparison: Ayurveda vs. Allopathy for Diabetic Neuropathy
| Aspect | Ayurveda | Allopathy |
|---|---|---|
| Focus | Root-cause treatment by balancing doshas and detoxifying the body (Chauhan, 2021). | Symptom management through painkillers and nerve-modulating drugs (American Diabetes Association, 2022). |
| Treatments | Abhyanga, herbal medications, detox therapies, and dietary changes (Gupta & Singh, 2017). | Medications like pregabalin, gabapentin, or antidepressants for nerve pain (Jones & Smith, 2020). |
| Sustainability | Promotes long-term nerve health by addressing systemic imbalances (Sharma, 2018). | Effective for symptom relief but requires continuous use of medication (Brown & White, 2018). |
| Side Effects | Minimal when administered under expert supervision (Chauhan, 2021). | Common side effects include drowsiness, weight gain, and gastrointestinal issues (American Diabetes Association, 2022). |
Success Stories from the Diabetes Reversal Clinic
Case 1: Recovery from Peripheral Neuropathy
- Patient Profile: A 55-year-old male with chronic Type 2 diabetes and numbness in feet (EliteAyurveda, 2023).
- Ayurvedic Intervention: Abhyanga with Bala Taila, Ashwagandha supplements, and a Kapha-pacifying diet (EliteAyurveda, 2023).
- Outcome: Within three months, the patient reported improved sensation in the feet and reduced pain levels (EliteAyurveda, 2023).
Case 2: Managing Autonomic Neuropathy
- Patient Profile: A 48-year-old female experiencing digestive issues and dizziness (EliteAyurveda, 2023).
- Ayurvedic Intervention: Herbal teas, Triphala churna for digestion, and pranayama practices (EliteAyurveda, 2023).
- Outcome: Improved digestion and stabilization of blood pressure within two months (EliteAyurveda, 2023).
Practical Tips for Patients with Diabetic Neuropathy
- Control Blood Sugar: Maintaining stable glucose levels is critical for preventing further nerve damage (American Diabetes Association, 2022).
- Incorporate Healthy Fats: Ghee and omega-3-rich foods can support nerve health (Gupta & Singh, 2017).
- Practice Regular Massage: Weekly oil massages can soothe pain and improve circulation (Chauhan, 2021).
- Stay Active: Gentle exercises like walking and yoga help maintain blood flow to the extremities (Sharma, 2018).
- Consult Experts: Seek Ayurvedic treatment tailored to your unique constitution and symptoms (EliteAyurveda, 2023).
From the Doctor’s Desk
Dr. Soumya Hullanavar shares her insights:
“Diabetic neuropathy is not just a complication; it’s a signal of systemic imbalances caused by long-standing diabetes. At the Diabetes Reversal Clinic, our Ayurvedic approach focuses on restoring harmony in the body through detoxification, nerve nourishment, and lifestyle modifications. This holistic care empowers patients to alleviate symptoms and regain their quality of life” (Hullanavar, 2023).
Why Choose the Diabetes Reversal Clinic?
- Holistic Approach: Combining traditional Ayurvedic wisdom with modern insights.
- Personalized Care: Tailored treatment plans to address individual needs (EliteAyurveda, 2023).
- Sustainable Outcomes: Focus on long-term nerve health and diabetes reversal (Sharma, 2018).
- Expert Guidance: Led by Dr. Soumya Hullanavar, a leading Ayurvedic endocrinologist (Hullanavar, 2023).
Conclusion
Diabetic neuropathy is a challenging complication of diabetes, but it can be effectively managed and even reversed with the right approach. Ayurveda’s emphasis on addressing the root cause, calming Vata dosha, and nourishing nerves offers a sustainable and holistic pathway to recovery. At the Diabetes Reversal Clinic, we empower patients to regain control over their health and lead fulfilling lives.
📞 Contact us today: +91 8884722267
🌐 Visit: Diabetes Reversal Clinic
Rediscover balance, vitality, and health with Ayurveda!
Related-
Know more about Ayurveda Diabetes Reversal Treatments.
GET IN TOUCH
Schedule a Visit
References
References
Saeedi, P.; Petersohn, I.; Salpea, P.; Malanda, B.; Karuranga, S.; Unwin, N.; Colagiuri, S.; Guariguata, L.; Motala, A.A.; Ogurtsova, K.; et al. Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Res. Clin. Pract. 2019, 157, 107843. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Pop-Busui, R.; Ang, L.; Boulton, A.J.M.; Feldman, E.L.; Marcus, R.L.; Mizokami-Stout, K.; Singleton, J.R.; Ziegler, D. Diag-nosis and Treatment of Painful Diabetic Peripheral Neuropathy. ADA Clin. Compend. 2022, 2022, 1–32. [Google Scholar] [CrossRef]
Vileikyte, L.; Gonzalez, J.S. Chapter 14—Recognition and Management of Psychosocial Issues in Diabetic Neuropathy. In Handbook of Clinical Neurology; Zochodne, D.W., Malik, R.A., Eds.; Diabetes and the Nervous System; Elsevier: Amsterdam, The Netherlands, 2014; Volume 126, pp. 195–209. [Google Scholar]
Pop-Busui, R.; Boulton, A.J.M.; Feldman, E.L.; Bril, V.; Freeman, R.; Malik, R.A.; Sosenko, J.M.; Ziegler, D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017, 40, 136–154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Hex, N.; Bartlett, C.; Wright, D.; Taylor, M.; Varley, D. Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK, Including Direct Health Costs and Indirect Societal and Productivity Costs. Diabet. Med. 2012, 29, 855–862. [Google Scholar] [CrossRef]
Kerr, M.; Barron, E.; Chadwick, P.; Evans, T.; Kong, W.M.; Rayman, G.; Sutton-Smith, M.; Todd, G.; Young, B.; Jeffcoate, W.J. The Cost of Diabetic Foot Ulcers and Amputations to the National Health Service in England. Diabet. Med. 2019, 36, 995–1002. [Google Scholar] [CrossRef]
Feldman, E.L.; Callaghan, B.C.; Pop-Busui, R.; Zochodne, D.W.; Wright, D.E.; Bennett, D.L.; Bril, V.; Russell, J.W.; Viswanathan, V. Diabetic Neuropathy. Nat. Rev. Dis. Primer 2019, 5, 41. [Google Scholar] [CrossRef]
Sloan, G.; Selvarajah, D.; Tesfaye, S. Pathogenesis, Diagnosis and Clinical Management of Diabetic Sensorimotor Peripheral Neuropathy. Nat. Rev. Endocrinol. 2021, 17, 400–420. [Google Scholar] [CrossRef]
Smith, S.; Normahani, P.; Lane, T.; Hohenschurz-Schmidt, D.; Oliver, N.; Davies, A.H. Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes. Life 2022, 12, 1074. [Google Scholar] [CrossRef]
Malik, R.A.; Tesfaye, S.; Newrick, P.G.; Walker, D.; Rajbhandari, S.M.; Siddique, I.; Sharma, A.K.; Boulton, A.J.M.; King, R.H.M.; Thomas, P.K.; et al. Sural Nerve Pathology in Diabetic Patients with Minimal but Progressive Neuropathy. Diabetologia 2005, 48, 578–585. [Google Scholar] [CrossRef]
Dey, I.; Midha, N.; Singh, G.; Forsyth, A.; Walsh, S.K.; Singh, B.; Kumar, R.; Toth, C.; Midha, R. Diabetic Schwann Cells Suffer from Nerve Growth Factor and Neurotrophin-3 Underproduction and Poor Associability with Axons. Glia 2013, 61, 1990–1999. [Google Scholar] [CrossRef]
Liu, Y.-P.; Shao, S.-J.; Guo, H.-D. Schwann Cells Apoptosis Is Induced by High Glucose in Diabetic Peripheral Neuropathy. Life Sci. 2020, 248, 117459. [Google Scholar] [CrossRef]
Padilla, A.; Descorbeth, M.; Almeyda, A.L.; Payne, K.; De Leon, M. Hyperglycemia Magnifies Schwann Cell Dysfunction and Cell Death Triggered by PA-Induced Lipotoxicity. Brain Res. 2011, 1370, 64–79. [Google Scholar] [CrossRef] [Green Version]
Baptista, F.I.; Pinheiro, H.; Gomes, C.A.; Ambrósio, A.F. Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies. Mol. Neurobiol. 2019, 56, 2202–2210. [Google Scholar] [CrossRef]
Ryle, C.; Donaghy, M. Non-Enzymatic Glycation of Peripheral Nerve Proteins in Human Diabetics. J. Neurol. Sci. 1995, 129, 62–68. [Google Scholar] [CrossRef]
Fernyhough, P.; Diemel, L.T.; Tomlinson, D.R. Target Tissue Production and Axonal Transport of Neurotrophin-3 Are Reduced in Streptozotocin-Diabetic Rats. Diabetologia 1998, 41, 300–306. [Google Scholar] [CrossRef] [Green Version]
Sima, A.A.; Lattimer, S.A.; Yagihashi, S.; Greene, D.A. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J. Clin. Investig. 1986, 77, 474–484. [Google Scholar] [CrossRef] [Green Version]
Said, G.; Slama, G.; Selva, J. Progressive Centripetal Degeneration of Axons in Small Fibre Diabetic Polyneuropathy: A Clinical and Pathological Study. Brain 1983, 106, 791–807. [Google Scholar] [CrossRef]
Zochodne, D.W. Chapter 26—Mechanisms of Diabetic Neuron Damage: Molecular Pathways. In Diabetes and the Nervous System; Elsevier: Amsterdam, The Netherlands, 2014; Volume 126, pp. 379–399. [Google Scholar]
Selvarajah, D.; Wilkinson, I.D.; Emery, C.J.; Harris, N.D.; Shaw, P.J.; Witte, D.R.; Griffiths, P.D.; Tesfaye, S. Early Involvement of the Spinal Cord in Diabetic Peripheral Neuropathy. Diabetes Care 2006, 29, 2664–2669. [Google Scholar] [CrossRef] [Green Version]
Malik, R.A.; Newrick, P.G.; Sharma, A.K.; Jennings, A.; Ah-See, A.K.; Mayhew, T.M.; Jakubowski, J.; Boulton, A.J.; Ward, J.D. Microangiopathy in Human Diabetic Neuropathy: Relationship between Capillary Abnormalities and the Severity of Neuropathy. Diabetologia 1989, 32, 92–102. [Google Scholar] [CrossRef] [Green Version]
Yasuda, H.; Dyck, P.J. Abnormalities of Endoneurial Microvessels and Sural Nerve Pathology in Diabetic Neuropathy. Neurology 1987, 37, 20–28. [Google Scholar] [CrossRef]
Tesfaye, S.; Harris, N.; Jakubowski, J.J.; Mody, C.; Wilson, R.M.; Rennie, I.G.; Ward, J.D. Impaired Blood Flow and Arterio-Venous Shunting in Human Diabetic Neuropathy: A Novel Technique of Nerve Photography and Fluorescein Angiography. Diabetologia 1993, 36, 1266–1274. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Dyck, P.J.; Lais, A.; Karnes, J.L.; O’Brien, P.; Rizza, R. Fiber Loss Is Primary and Multifocal in Sural Nerves in Diabetic Polyneuropathy. Ann. Neurol. 1986, 19, 425–439. [Google Scholar] [CrossRef] [PubMed]
Shi, Y.; Vanhoutte, P.M. Macro- and Microvascular Endothelial Dysfunction in Diabetes. J. Diabetes 2017, 9, 434–449. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Madonna, R.; Balistreri, C.R.; Geng, Y.-J.; De Caterina, R. Diabetic Microangiopathy: Pathogenetic Insights and Novel Therapeutic Approaches. Vascul. Pharmacol. 2017, 90, 1–7. [Google Scholar] [CrossRef] [Green Version]
Quattrini, C.; Jeziorska, M.; Boulton, A.J.M.; Malik, R.A. Reduced Vascular Endothelial Growth Factor Expression and Intra-Epidermal Nerve Fiber Loss in Human Diabetic Neuropathy. Diabetes Care 2008, 31, 140–145. [Google Scholar] [CrossRef] [Green Version]
Britland, S.T.; Young, R.J.; Ashutosh, S.K.; Clarke, B.F. Relationship of Endoneurial Capillary Abnormalities to Type and Severity of Diabetic Polyneuropathy. Diabetes 1990, 39, 909–913. [Google Scholar] [CrossRef]
Malik, R.A.; Veves, A.; Masson, E.A.; Sharma, A.K.; Ah-See, A.K.; Schady, W.; Lye, R.H.; Boulton, A.J. Endoneurial Capillary Abnormalities in Mild Human Diabetic Neuropathy. J. Neurol. Neurosurg. Psychiatry 1992, 55, 557–561. [Google Scholar] [CrossRef] [Green Version]
